Saturday, 31 October 2026European Markets

ABC ARBITRAGE, TINC, Another 1 Companies Have A High Dividend Yield And Return On Equity In The Asset Management Industry.

Loading stream...

(vianews) - abc arbitrage (abca.pa) is among this list of stock assets with the highest dividend rate and return on equity on the asset management industry.

financial asset price forward dividend yield return on equity
abc arbitrage (abca.pa) €3.72 9.34% 13.59%
tinc (tinc.br) €11.35 4.6% 6.13%
peugeot invest (peug.pa) €106.60 2.78% 6.37%

several euronext companies pay out dividends to its shareholders. the dividend yield is a dividend to price ratio showing how much a company pays out in dividends each year.

1. abc arbitrage (abca.pa)

9.34% forward dividend yield and 13.59% return on equity

abc arbitrage sa, together with its subsidiaries, engages in the development of arbitrage strategies for liquid assets worldwide. it develops liquidity, statistical, risk, and derivatives arbitrage strategies; and provides asset and portfolio management services. the company was incorporated in 1995 and is based in paris, france.

earnings per share

as for profitability, abc arbitrage has a trailing twelve months eps of €0.37.

pe ratio

abc arbitrage has a trailing twelve months price to earnings ratio of 10.05. meaning, the purchaser of the share is investing €10.05 for every euro of annual earnings.

return on equity

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 13.59%.

more news about abc arbitrage.

2. tinc (tinc.br)

4.6% forward dividend yield and 6.13% return on equity

tinc comm. va is an investment firm specializing in investments in public and private infrastructure, real assets, and energy sector. tinc comm. va is based in antwerpen, belgium.

earnings per share

as for profitability, tinc has a trailing twelve months eps of €1.01.

pe ratio

tinc has a trailing twelve months price to earnings ratio of 11.24. meaning, the purchaser of the share is investing €11.24 for every euro of annual earnings.

return on equity

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 6.13%.

more news about tinc.

3. peugeot invest (peug.pa)

2.78% forward dividend yield and 6.37% return on equity

peugeot invest société anonyme operates as an investment company. the firm invests in private equity and real estate funds. the firm also invests in governance, social, and environmental protection. the company was formerly known as ffp société anonyme and changed its name to peugeot invest société anonyme. peugeot invest société anonyme was incorporated in 1929 and is headquartered in paris, france.

earnings per share

as for profitability, peugeot invest has a trailing twelve months eps of €11.95.

pe ratio

peugeot invest has a trailing twelve months price to earnings ratio of 8.92. meaning, the purchaser of the share is investing €8.92 for every euro of annual earnings.

return on equity

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 6.37%.

moving average

peugeot invest's worth is above its 50-day moving average of €101.15 and higher than its 200-day moving average of €100.16.

volatility

peugeot invest's last week, last month's, and last quarter's current intraday variation average was 1.65%, 0.39%, and 0.90%.

peugeot invest's highest amplitude of average volatility was 1.65% (last week), 1.27% (last month), and 0.90% (last quarter).

more news about peugeot invest.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
ESMO 2026 Oncology Data Wave Builds Toward Ivonescimab PDUFA, While Micro-Cap Biotech Exits the Market
Late October 2026 is a dense catalyst window led by ESMO 2026. Daiichi Sankyo's DXd antibody-drug conjugate (ADC) programs (DESTINY-Lung04, DESTINY-Breast11, REJOICE-Ovarian01/02, TUXEDO-3), Guardant's 25 abstracts and the PACE-LUNG ctDNA trial all report there. These feed into the FDA's 14 November 2026 PDUFA date for ivonescimab. Large and mid-cap developers with late-stage data and commercial launches (ZEGFROVY, ANKTIVA, MIUDELLA, lorundrostat, duvakitug) are drawing capital and attention. Spago Nanomedical's board decision to seek a Nasdaq First North delisting (EGM 19 November, application 25 January 2027) shows the capital squeeze on early-stage, single-asset names (Tumorad is Phase I).
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,995
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,995 facts checked against source5,514 source documents archived
Query this data → isubstrate.com